Craft

Syneos Health

Stock Price

$42.7

2023-09-01

Market Capitalization

$4.4 B

2023-09-01

Revenue

$5.4 B

FY, 2022

Syneos Health Summary

Company Summary

Overview
Syneos Health (formerly known as INC Research) is a contract research organization that provides various clinical development services for the biopharmaceutical and medical device industries. Its operations are divided into two segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers a variety of services spanning clinical development, including clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.
Type
Public
Status
Active
Founded
1998
HQ
Morrisville, NC, US | view all locations
Website
https://www.syneoshealth.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Michelle Keefe

    Michelle Keefe, Chief Executive Officer and Director

  • Jason Meggs

    Jason Meggs, Chief Financial Officer

  • Lisa van Capelle

    Lisa van Capelle, Chief Human Resources Officer

  • Larry A. Pickett

    Larry A. Pickett, Chief Information & Digital Officer

Operating MetricsView all

Backlog

$9.8B
15.5%

Q1, 2023

Facilities

96
15.0%

FY, 2022

Backlog (Clinical Solutions)

$9B
16.7%

Q1, 2023

LocationsView all

78 locations detected

  • Morrisville, NC HQ

    United States

    1030 Sync St

  • Blue Bell, PA

    United States

    1787 Sentry Pkwy W Building 18, Suite 300

  • Boston, MA

    United States

    470 Atlantic Ave 11th floor

  • Carlsbad, CA

    United States

    5909 Sea Otter Pl

  • Charlotte, NC

    United States

    11525 N. Community House Road

  • Miami, FL

    United States

    1951 NW 7th Ave #450

and 72 others

Syneos Health Financials

Summary Financials

Revenue (Q2, 2023)
$1.4B
Gross profit (Q2, 2023)
$294.7M
Net income (Q2, 2023)
$793.0K
Cash (Q2, 2023)
$82.3M
EBIT (Q2, 2023)
$42.2M
Enterprise value
$7.0B

Footer menu